{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "2552784", "DateCompleted": {"Year": "1989", "Month": "11", "Day": "02"}, "DateRevised": {"Year": "2019", "Month": "06", "Day": "26"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0002-8703", "JournalIssue": {"Volume": "118", "Issue": "4", "PubDate": {"Year": "1989", "Month": "Oct"}}, "Title": "American heart journal", "ISOAbbreviation": "Am Heart J"}, "ArticleTitle": "OPC-88117 suppresses early and delayed afterdepolarizations and arrhythmias induced by cesium, 4-aminopyridine and digitalis in canine Purkinje fibers and in the canine heart in situ.", "Pagination": {"StartPage": "708", "EndPage": "716", "MedlinePgn": "708-16"}, "Abstract": {"AbstractText": ["The effects of OPC-88117, a new investigational antiarrhythmic drug, on early and delayed afterdepolarizations (EAD and DAD, respectively) were assessed in vitro in canine Purkinje fibers and in vivo in the canine right ventricle. OPC-88117 had similar electrophysiologic properties to class I antiarrhythmic agents in that it decreased Vmax. OPC-88117 decreased the amplitude and prolonged the coupling interval of DAD induced by acetylstrophanthidin. Likewise, OPC-88117 suppressed EAD induced in vitro by 4-aminopyridine. In vivo, cesium-induced EAD, ventricular arrhythmia, and atrioventricular block were suppressed by OPC-88117. In summary, OPC-88117 suppressed DAD and EAD in vitro and inhibited EAD and triggered activity in the in situ canine heart."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Krannert Institute of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis."}], "LastName": "Graham", "ForeName": "B", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Gilmour", "ForeName": "R F", "Initials": "RF", "Suffix": "Jr"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Stanton", "ForeName": "M S", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Zipes", "ForeName": "D P", "Initials": "DP"}], "GrantList": [{"GrantID": "HL-06308", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HL-07182", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am Heart J", "NlmUniqueID": "0370465", "ISSNLinking": "0002-8703"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cardiovascular Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Piperazines"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinolones"}, {"RegistryNumber": "113225-73-3", "NameOfSubstance": "8-methyl-3-(4-methyl-1-piperazinyl)-2(1H)-quinolinone"}, {"RegistryNumber": "1KSV9V4Y4I", "NameOfSubstance": "Cesium"}, {"RegistryNumber": "BH3B64OKL9", "NameOfSubstance": "4-Aminopyridine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "4-Aminopyridine"}, {"QualifierName": ["drug effects"], "DescriptorName": "Action Potentials"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemically induced", "drug therapy", "physiopathology"], "DescriptorName": "Arrhythmias, Cardiac"}, {"QualifierName": [], "DescriptorName": "Cardiovascular Agents"}, {"QualifierName": [], "DescriptorName": "Cesium"}, {"QualifierName": [], "DescriptorName": "Digitalis"}, {"QualifierName": [], "DescriptorName": "Dogs"}, {"QualifierName": [], "DescriptorName": "Electrocardiography"}, {"QualifierName": ["drug effects"], "DescriptorName": "Heart"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Heart Block"}, {"QualifierName": [], "DescriptorName": "Heart Conduction System"}, {"QualifierName": ["drug effects"], "DescriptorName": "Membrane Potentials"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Piperazines"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Plants, Toxic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Purkinje Fibers"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Quinolones"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1989", "Month": "10", "Day": "1"}, {"Year": "2001", "Month": "3", "Day": "28", "Hour": "10", "Minute": "1"}, {"Year": "1989", "Month": "10", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["2552784", "10.1016/0002-8703(89)90583-8", "0002-8703(89)90583-8"]}}]}